Ikuko Ueda‐Hayakawa

949 total citations
32 papers, 427 citations indexed

About

Ikuko Ueda‐Hayakawa is a scholar working on Epidemiology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Ikuko Ueda‐Hayakawa has authored 32 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Pathology and Forensic Medicine and 10 papers in Dermatology. Recurrent topics in Ikuko Ueda‐Hayakawa's work include Sarcoidosis and Beryllium Toxicity Research (8 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Ikuko Ueda‐Hayakawa is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (8 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Ikuko Ueda‐Hayakawa collaborates with scholars based in Japan, Vietnam and United States. Ikuko Ueda‐Hayakawa's co-authors include Hiroyuki Okamoto, Naotomo Kambe, Josh Mahlios, Yuan Zhuang, Manabu Fujimoto, Fumikazu Yamazaki, Kana Mizuno, Minoru Hasegawa, Kazuhiko Takehara and Yasuhito Hamaguchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and British Journal of Dermatology.

In The Last Decade

Ikuko Ueda‐Hayakawa

26 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikuko Ueda‐Hayakawa Japan 13 157 130 127 109 92 32 427
Shunli Tang China 11 215 1.4× 36 0.3× 39 0.3× 118 1.1× 87 0.9× 24 496
H. Fernández‐Llaca Spain 10 49 0.3× 181 1.4× 82 0.6× 54 0.5× 100 1.1× 19 438
Magdalena Dziadzio United Kingdom 9 130 0.8× 68 0.5× 30 0.2× 286 2.6× 52 0.6× 21 475
Reika Maezawa Japan 12 109 0.7× 162 1.2× 27 0.2× 66 0.6× 356 3.9× 28 512
Sophie Toya United States 11 83 0.5× 259 2.0× 131 1.0× 126 1.2× 123 1.3× 16 511
MA Gürer Türkiye 10 94 0.6× 39 0.3× 37 0.3× 47 0.4× 98 1.1× 14 383
Gemma Sais Spain 11 46 0.3× 201 1.5× 27 0.2× 73 0.7× 126 1.4× 20 400
Carol R. Drucker United States 9 62 0.4× 38 0.3× 25 0.2× 121 1.1× 60 0.7× 13 477
Natalia Palmou‐Fontana Spain 13 131 0.8× 90 0.7× 19 0.1× 50 0.5× 70 0.8× 27 508
M. Vogelbruch Germany 7 76 0.5× 28 0.2× 72 0.6× 117 1.1× 56 0.6× 10 381

Countries citing papers authored by Ikuko Ueda‐Hayakawa

Since Specialization
Citations

This map shows the geographic impact of Ikuko Ueda‐Hayakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuko Ueda‐Hayakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuko Ueda‐Hayakawa more than expected).

Fields of papers citing papers by Ikuko Ueda‐Hayakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuko Ueda‐Hayakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuko Ueda‐Hayakawa. The network helps show where Ikuko Ueda‐Hayakawa may publish in the future.

Co-authorship network of co-authors of Ikuko Ueda‐Hayakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuko Ueda‐Hayakawa. A scholar is included among the top collaborators of Ikuko Ueda‐Hayakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuko Ueda‐Hayakawa. Ikuko Ueda‐Hayakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamaguchi, Yasuhito, Ikuko Ueda‐Hayakawa, Utako Kaneko, et al.. (2025). Nationwide epidemiological and clinical survey of juvenile‐onset morphea in Japan. The Journal of Dermatology. 52(5). 860–871. 1 indexed citations
2.
Nakagawa, Seitaro, Ikuko Ueda‐Hayakawa, & Manabu Fujimoto. (2025). Nemolizumab for treatment of lichen amyloidosis. JAAD Case Reports. 63. 41–43.
3.
Kotobuki, Yorihisa, et al.. (2022). Exacerbation of livedoid vasculopathy after coronavirus disease 2019. European Journal of Dermatology. 32(1). 129–131. 3 indexed citations
4.
Ueda‐Hayakawa, Ikuko, Akihiro Tanaka, Fumikazu Yamazaki, et al.. (2022). Panniculitis in dermatomyositis: Two cases with antitranscriptional intermediary factor‐1 antibody as myositis‐specific antibody and review of the literature. SHILAP Revista de lepidopterología. 5(3). 88–93. 2 indexed citations
5.
Ueda‐Hayakawa, Ikuko, et al.. (2021). Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies. Journal of Dermatological Science. 104(3). 177–184. 7 indexed citations
6.
Arase, Noriko, Hideaki Tsuji, Hyota Takamatsu, et al.. (2021). Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Journal of Autoimmunity. 126. 102774–102774. 6 indexed citations
7.
Ueda‐Hayakawa, Ikuko, et al.. (2020). Exploring the imbalance of circulating follicular helper CD4+ T cells in sarcoidosis patients. Journal of Dermatological Science. 97(3). 216–224. 15 indexed citations
8.
9.
10.
Kambe, Naotomo, et al.. (2018). Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis. Journal of Dermatological Science. 90(2). 135–143. 17 indexed citations
11.
Matsuda, Tomoko, Fumikazu Yamazaki, Ikuko Ueda‐Hayakawa, Naotomo Kambe, & Hiroyuki Okamoto. (2018). Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin‐17A, but improved after blockade of interleukin‐12/23 p40. The Journal of Dermatology. 46(1). 70–72. 17 indexed citations
12.
Mizuno, Kana, et al.. (2017). Annular lesions of cutaneous sarcoidosis with granulomatous vasculitis. Journal of Cutaneous Pathology. 44(5). 494–496. 12 indexed citations
13.
Matsuda, Tomoko, et al.. (2017). Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work. The Journal of Dermatology. 45(3). 344–348. 16 indexed citations
14.
15.
Ueda‐Hayakawa, Ikuko, et al.. (2016). Ultrastructural analysis of pigmentary mosaicism: reduced melanosome granules within melanocytes. European Journal of Dermatology. 26(4). 388–389.
16.
Hamaguchi, Yasuhito, Takashi Matsushita, Minoru Hasegawa, et al.. (2013). High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies. Modern Rheumatology. 25(5). 798–801. 9 indexed citations
17.
Ueda‐Hayakawa, Ikuko, Minoru Hasegawa, Yasuhito Hamaguchi, Kazuhiko Takehara, & Manabu Fujimoto. (2012). Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. Journal of Dermatological Science. 69(1). 54–60. 17 indexed citations
18.
Ueda‐Hayakawa, Ikuko, Minoru Hasegawa, Chihiro Tanaka, et al.. (2010). Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Lara D. Veeken. 49(11). 2135–2139. 25 indexed citations
19.
Ueda‐Hayakawa, Ikuko, Josh Mahlios, & Yuan Zhuang. (2009). Id3 Restricts the Developmental Potential of γδ Lineage during Thymopoiesis. The Journal of Immunology. 182(9). 5306–5316. 69 indexed citations
20.
Mugii, Naoki, Minoru Hasegawa, Chihiro Tanaka, et al.. (2009). Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Lara D. Veeken. 48(6). 696–703. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunli Tang Breakdown of academic impact, for papers by H. Fernández‐Llaca Breakdown of academic impact, for papers by Magdalena Dziadzio Breakdown of academic impact, for papers by Reika Maezawa Breakdown of academic impact, for papers by Sophie Toya Breakdown of academic impact, for papers by MA Gürer Breakdown of academic impact, for papers by Gemma Sais Breakdown of academic impact, for papers by Carol R. Drucker Breakdown of academic impact, for papers by Natalia Palmou‐Fontana Breakdown of academic impact, for papers by M. Vogelbruch
Rankless by CCL
2026